Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 20306 | SRI-37330 HCl | 2322245-49-6 | ≧98.0% |  |
| SRI-37330 hydrochloride is a novel inhibitor of TXNIP expression,and dose-dependently | ||||
| 20308 | 4-(chloromethyl)-1-cyclopentyl-2-(trifluoromethyl)benzene | 957208-65-0 | ≧98.0% | -1-cyclopentyl-2-(trifluoromethyl)benzene_957208-65-0.png) |
| 20310 | 4-chloro-6-(trifluoromethyl)quinazoline | 16499-64-2 | 98% Min. |  |
| 20311 | 6-(TRIFLUOROMETHYL)QUINAZOLIN-4(3H)-ONE | 16544-67-5 | 98% Min. | QUINAZOLIN-4(3H)-ONE_16544-67-5.png) |
| 20312 | 2-AMINO-5-TRIFLUOROMETHYL-BENZOIC ACID | 83265-53-6 | 98% Min. |  |
| 20314 | Obicetrapib | 866399-87-3 | 98% Min. |  |
| Obicetrapib (also known as AMG-899, TA-8995, and DEX-001) is a cholesteryl ester tran | ||||
| 20318 | Zotizalkib ( TPX-0131 ) | 2648641-36-3 | ≧98.0% | _2648641-36-3.png) |
| TPX-0131 is a next-generation ALK inhibitor drug candidate currently being evaluated | ||||
| 20344 | SMN-C3 | 1449597-34-5 | ≧98.0% |  |
| SMN-C3is an orally active SMN2 splicing modulator and has the potential to treat spin | ||||
| 226191 | AGN 196996 | 958295-17-5 | ≧98.0% |  |
| AGN 196996 is a potent and selective RARα antagonist with Ki value of 2 nM; little b | ||||
| 20368 | SHMT-IN-2 | 2102681-49-0 | ≧98.0% |  |
| SHMT-IN-2 is a serine hydroxymethyltransferase (SHMT) inhibitor, potently inhibiting | ||||
| 20369 | Sunvozertinib ( DZD 9008 ) | 2370013-12-8 | ≧98.0% | _2370013-12-8.png) |
| Sunvozertinib, also known as DZD9008, is an oral, potent, irreversible, and selective | ||||
| 1711223 | Asciminib HCl | 2119669-71-3 | ≧98.0% |  |
| Asciminib, also known as ABL001, is a potent allosteric inhibitor of BCR-ABL. | ||||